Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Than Endoscopic Gastric Atrophy Classification and OLGIM Stage: A Prospective Study

NCT02562976 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.

NCT NCT02562976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02562976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Than Endoscopic Gastric Atrophy Classification and OLGIM Stage: A Prospective Study
Lead sponsor
Shanghai Jiao Tong University School of Medicine
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
July 31, 2015
Enrollment
227 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

early gastric cancer